Adastra Holdings Ltd. (XTXXF)
OTCMKTS · Delayed Price · Currency is USD
0.0100
0.00 (0.00%)
Feb 10, 2026, 9:30 AM EST
Adastra Holdings Revenue
Adastra Holdings had revenue of 4.74M CAD in the quarter ending September 30, 2025, a decrease of -33.22%. This brings the company's revenue in the last twelve months to 16.86M, down -32.84% year-over-year. In the year 2024, Adastra Holdings had annual revenue of 24.84M with 11.79% growth.
Revenue (ttm)
16.86M CAD
Revenue Growth
-32.84%
P/S Ratio
0.07
Revenue / Employee
n/a
Employees
n/a
Market Cap
865.70K USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 24.84M | 2.62M | 11.79% |
| Dec 31, 2023 | 22.22M | 8.93M | 67.15% |
| Dec 31, 2022 | 13.30M | 7.67M | 136.21% |
| Dec 31, 2021 | 5.63M | 3.13M | 125.20% |
| Dec 31, 2020 | 2.50M | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tian'an Pharmaceutical | 10.65M |
| Target Group | 5.00M |
| Pure Harvest Corporate Group | 2.48M |
| Resonate Blends | 2.23M |
| Global Roundtable | 1.24M |
| TransGlobal Assets | 91.35K |
| CBD of Denver | 42.50K |
| Premier Biomedical | 14.28K |
Adastra Holdings News
- 4 months ago - Adastra Holdings Announces Completion of Sale of Subsidiaries - Newsfile Corp
- 4 months ago - Adastra Holdings (XTXXF) Divests Subsidiaries to Enhance Financial Health - GuruFocus
- 4 months ago - Adastra Holdings sells subsidiaries for $4M to streamline operations and cut debt - Seeking Alpha
- 4 months ago - Adastra Holdings Enters into Agreements to Sell Subsidiaries - Newsfile Corp